| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 16/04/2024 | 14:05 | PR Newswire (US) | PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 27/03/2024 | 13:00 | PR Newswire (US) | Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 22/03/2024 | 21:30 | PR Newswire (US) | PacBio Grants Equity Incentive Award to New Employee | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 12/03/2024 | 14:05 | PR Newswire (US) | PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 06/03/2024 | 23:36 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 05/03/2024 | 00:32 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 26/02/2024 | 22:05 | PR Newswire (US) | PacBio to Present at Upcoming Investor Conferences | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 15/02/2024 | 22:07 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 15/02/2024 | 22:05 | PR Newswire (US) | PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 13/02/2024 | 22:15 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 13/02/2024 | 13:00 | PR Newswire (US) | Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 05/02/2024 | 15:05 | PR Newswire (US) | PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 25/01/2024 | 22:03 | PR Newswire (US) | PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024 | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 15/01/2024 | 15:05 | PR Newswire (US) | PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 08/01/2024 | 14:00 | PR Newswire (US) | PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 27/12/2023 | 22:05 | PR Newswire (US) | PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 11/12/2023 | 14:00 | PR Newswire (US) | PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 03/11/2023 | 21:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 02/11/2023 | 14:05 | PR Newswire (US) | PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 01/11/2023 | 14:05 | PR Newswire (US) | PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 31/10/2023 | 14:05 | PR Newswire (US) | PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 30/10/2023 | 21:03 | PR Newswire (US) | PacBio Announces Third Quarter 2023 Financial Results | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 27/10/2023 | 23:00 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 19/10/2023 | 22:10 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 16/10/2023 | 14:12 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 16/10/2023 | 14:05 | PR Newswire (US) | PacBio Announces Appointment of David Meline to Board of Directors | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 12/10/2023 | 22:03 | PR Newswire (US) | PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023 | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 11/10/2023 | 15:05 | PR Newswire (US) | PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 03/10/2023 | 22:20 | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NASDAQ:PACB | Pacific Biosciences of California Inc |
| 12/09/2023 | 14:00 | PR Newswire (US) | PacBio Announces PacBio Capital | NASDAQ:PACB | Pacific Biosciences of California Inc |